Therefore, the purposes of this study were to investigate differences in muscle quality and muscle growth factors (i.e., GDF-15, myostatin, activin A, and follistatin) between sarcopenia and non-sarcopenia in elderly women and identify the potential diagnostic tool that develops sarcopenia in this population. Here, MSTN is linked to sarcopenia.